Angelo Tagliabue
- General Dentistry top 1%
- Periodontics top 2%
- Oral Health Pathology and Treatment 5
- Oral microbiology and periodontitis research 3
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 3
- Orthodontics top 5%
-
- Salivary Gland Disorders and Functions 5
-
- Dental Implant Techniques and Outcomes 4
- Oral and Maxillofacial Pathology 4
-
- Oral and gingival health research 4
-
- Bacterial Infections and Vaccines 3
Angelo Tagliabue
36 papers receiving 962 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- General Dentistry 155
- Periodontics 130
- Infectious Diseases 516
- Orthodontics 59
- Complementary and Manual Therapy 29
Countries citing papers authored by Angelo Tagliabue
This map shows the geographic impact of Angelo Tagliabue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Tagliabue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Tagliabue more than expected).
Fields of papers citing papers by Angelo Tagliabue
This network shows the impact of papers produced by Angelo Tagliabue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Tagliabue. The network helps show where Angelo Tagliabue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angelo Tagliabue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 23 | |
| 3 | 2021 | 142 | |
| 4 | 2021 | 40 | |
| 5 | Saliva is a reliable tool to detect SARS-CoV-2breakdown → | 2020 | 436 |
| 6 | 2020 | 5 | |
| 7 | Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review. | 2019 | 25 |
| 8 | Comparison of linear transverse measures between plaster and resin printed digital models. | 2019 | 56 |
| 9 | Foxo3a re-expression overcomes tamoxifen resistance in breast cancer. | 2019 | 4 |
| 10 | Zinc plus octenidine: a new formulation for treating periodontal pathogens. A single blind study. | 2019 | 6 |
| 11 | Focus on periodontal disease and development of endocarditis. | 2019 | 41 |
| 12 | The role of zinc plus octenidine in the regulation of gene expression: an in vitro study. | 2018 | 4 |
| 13 | 2017 | 3 | |
| 14 | 2014 | 38 | |
| 15 | Oral lipoma: Many features of a rare oral benign neoplasm | 2014 | 3 |
| 16 | 2013 | 1 | |
| 17 | 2012 | 6 | |
| 18 | 2011 | 31 | |
| 19 | Prevalence of malocclusion in preschool and primary school children with habitual snoring and sleep-disordered breathing. | 2011 | 14 |
| 20 | Philippe self-ligating lingual brackets. | 2002 | 11 |
About Angelo Tagliabue
Angelo Tagliabue is a scholar working on Periodontics, Oral Surgery and General Dentistry, having authored 36 papers that have together received 983 indexed citations. Recurring topics across this work include Oral Health Pathology and Treatment (5 papers), Salivary Gland Disorders and Functions (5 papers), Dental Implant Techniques and Outcomes (4 papers), Oral and Maxillofacial Pathology (4 papers), Oral and gingival health research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Oral microbiology and periodontitis research (3 papers) and Bacterial Infections and Vaccines (3 papers). The work is most often cited by research in General Dentistry (155 citations), Periodontics (130 citations) and Infectious Diseases (516 citations). Angelo Tagliabue has collaborated with scholars based in Italy, China and Spain. Frequent co-authors include L Tettamanti, Lorenzo Azzi, Vittorio Maurino, Andreina Baj, Giulio Carcano, Francesco Gianfagna, Daniela Dalla Gasperina, Francesco Carinci, Fausto Sessa and Angelo Genoni. Their work appears in journals such as Frontiers in Immunology, EBioMedicine and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.